Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns

Acta Tropica

Volumn 86, Issue 2-3, 2003, Pages 215-221

  Urbani, Carlo ^a   Albonico, Marco ^b  

^a Vectorborne/Other Parasitic Diseases   (Viet Nam)

^b Ivo de Carneri Foundation   (Italy)

Author keywords

Anthelminthic drugs; Drug safety; Periodic chemotherapy; Side effects

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; LEVAMISOLE; MEBENDAZOLE; PYRANTEL EMBONATE;

DISEASE CONTROL; DRUG PRESCRIBING; PARASITIC DISEASE;

ABDOMINAL PAIN; ALLERGY; BONE MARROW DEPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; COMMUNITY CARE; CONFERENCE PAPER; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG RECEPTOR BINDING; DRUG SAFETY; EDEMA; ENCEPHALITIS; EPIGASTRIC PAIN; GASTROINTESTINAL SYMPTOM; HEADACHE; HELMINTHIASIS; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LEUKOPENIA; LIVER DISEASE; MUSCLE WEAKNESS; NAUSEA; NEUTROPENIA; PARASITE TRANSMISSION; RASH; SIDE EFFECT; URTICARIA; VERTIGO; VOMITING; WORLD HEALTH ORGANIZATION;

VERMES;

EID: 0038064280     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00036-6     Document Type: Conference Paper

References (56)

1. Ajonuma L.C., Chika L.C. Outbreak of Stevens-Johnson syndrome among Filipino overseas contract workers using mebendazole for helminthiasis prophylaxis. Trop. Doct. 30:(1):2000;57.
2. Albonico M., Renganathan E., Bosman A., Uledi M.K., Kassim S.A., Savioli L. Efficacy of a single dose of mebendazole on prevalence and intensity of soil-transmitted nematodes in Zanzibar. Trop. Geogr. Med. 46:(3):1994;142-146.
3. Albonico M., Smith P.G., Hall A., Chwaya H.M., Alawi K.S., Savioli L. A randomised controlled trial comparing Mebendazole and Albendazole against Ascaris, Trichuris and the hookworms. Trans. R. Soc. Trop. Med. Hyg. 88:1994;585-589.
4. Albonico, M., Crompton, D.W.T., Savioli, L., 1999. Control Strategies for Human Intestinal Nematode Infections Adv. Parasitol. Baker, J.R, Muller, R., Rollingson, D., vol. 42, Academic Press, London, pp. 277-341.
5. Albonico, M., Bickle, Q., Haji, H.J., Ramsan, M., Khatib, J.K., Savioli, L., Taylor, M., 2002. Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Trans. R. Soc. Trop. Med. Hyg., in press.
6. Albonico, M., Bickle, Q., Ramsan, M., Montresor, A., Savioli, L., Taylor, M., 2003. Efficacy of mebendazole and levamisole alone or in combination for the treatment of intestinal nematode infections after targeted mebendazole treatment in Zanzibar. Bull. WHO, in press.
7. Aubry M.L., Cowell P., Davey M.J., Shevde S. Aspects of the pharmacology of a new anthelmintic: pyrantel. Br. J. Pharmacol. 38:1970;332-344.
8. Bennet A., Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol. Today. 16:(2):2000;71-74.
9. Bradley M., Horton J. Assessing the risk of benzimidazole therapy during pregnancy. Trans. R. Soc. Trop. Med. Hyg. 95:(1):2001;72-73.
10. Bundy D.A.P., Wong M.S., Lewis L.L., Horton J. Control of geohelminths by delivery of targeted chemotherapy through schools. Trans. R. Soc. Trop. Med. Hyg. 84:1990;115-120.
11. Bundy D.A.P., Hall A., Medley G.F., Savioli L. Evaluating measures to control intestinal parasitic infections. World Health Stat. Q. 45:1992;168-179.
12. Cabrera B.D., Valdez E.V., Go T.G. Clinical trials of broad spectrum anthelmintics against soil-transmitted helminthiasis. Southeast Asian J. Trop. Med. Public Health. 11:(4):1980;502-506.
13. Chavarria A.P., Swartzwelder J.C., Villarejos V.M., Zeledon R. Mebendazole, an effective, broad spectrum anthelminthic. Am. J. Trop. Med. Hyg. 22:1973;592-595.
14. Coulaud J.P., Rossignol J.F. Albendazole: a new single dose anthelminthic. Acta Trop. 47:1984;87-90.
15. Crompton D.W.T. How much human helminthiasis is there in the world. J. Parasitol. 85:(3):1999;397-403.
16. Davis A., Dixon H., Pawlowski Z.S. Multicenter clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bull. WHO. 67:1989;503-508.
17. Dawson M., Braithwaite P.A., Roberts M.S., Watson T.R. The pharmacokinetics and bioavailability of a tracer dose of (3H)-mebendazole in man. Br. J. Clin. Pharmacol. 19:1985;79-86.
18. De Silva N.R., Sirisena J.L., Gunasekera D.P., Ismail M.M., de Silva H.J. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet. 353:(9159):1999;1145-1149.
19. Farid Z., Bassily S., Miner W.F., Hassan A., Laughli L.W. Comparative single-dose treatment of hookworm and roundworm infections with levamisole, pyrantel and bephenium. J. Trop. Med. Hyg. 80:1977;107-108.
20. Fernandez Banares F., Gonzalez Huix F., Xiol X., Catala I., Miro J., Lopez N., Casais L. Marrow aplasia during high dose mebendazole treatment. Am. J. Trop. Med. Hyg. 35:(2):1986;350-351.
21. Gottschall D.W., Theodorides V.J., Wang R. The metabolism of benzimidazoles. Parasitol. Today. 6:1990;115-120.
22. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 121:2000;S113-S132.
23. Issaragrisil S., Kaufman D.W., Anderson T., Chansung K., Thamprasit T., Sirijirachai J., Piankijagum A., Porapakkham Y., Vannasaeng S., Leaverton P.E., Shapiro S., Young N.S. Low drug attributability of aplastic anemia in Thailand. Blood. 89:(11):1997;4034-4039.
24. Jung H., Hurtado M., Sanchez M., Medina M.T., Sotelo J. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Clin. Neuropharmacol. 13:1990;347-353.
25. Kammerer W.S., Schantz P.M. Long term follow up of human hydatid disease (Echinococcus granulosus) treated with a high dose mebendazole regimen. Am. J. Trop. Med. Hyg. 33:(1):1984;132-137.
26. Kouassi E., Caille G., Lery L., Lariviere L., Vezina M. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharmaceut. Drug Dispos. 7:(1):1986;71-89.
27. Lacey E. Mode of action of benzimidazoles. Parasitol. Today. 6:(4):1990;107-112.
28. Lim J.K. Anthelmintic effect of oxantel and oxantel-pyrantel in intestinal nematodes infections. Drugs. 15:(Suppl. 1):1978;37-41.
29. Lionel N.D., Mirando E.H., Nanayakkara J.C., Soysa P.E. Levamisole in the treatment of ascariasis in children. Br. Med. J. 4:1969;340-341.
30. Marriner S.E., Morris D.L., Dickson B., Bogan J.A. Pharmacokinetics of albendazole in man. Eur. J. Clin. Pharmacol. 30:1986;705-708.
31. Martin R.J. Neuromuscular transmission in nematodes parasites and antinematodal drug action. Pharmacol. Ther. 58:(1):1993;13-50.
32. Mbendi M., Mashako M.N., Lukuni M., Ndongala Z.L. L'albendazole dans le traitement des nematodes intestinales chez l'enfant age de1 a 2 ans. Med. Chir. Dig. 17:(3):1988;213-215.
33. Miskovitz P.F., Javitt N.B. Leukopenia associated with mebendazole therapy of hydatid disease. Am. J. Trop. Med. Hyg. 29:(6):1980;1356-1358.
34. Montresor, A., Crompton, D.W.T., Bundy, D.A.P., Hall, A., Savioli, L., 1998. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level, Division of Control of Tropical Diseases. WHO/CDS/SIP98.2. WHO, Geneva.
35. Montresor A., Stoltzfus R.J., Albonico M., Tielsch J.M., Rice A.L., Chwaya H.M., Savioli L. Is the exclusion of children under 24 months from anthelminthic treatment justifiable. Trans. R. Soc. Trop. Med. Hyg. 96:(2):2002;197-199.
36. Morris D.L., Smith P.G. Albendazole in hydatid diseases-hepatocellular toxicity. Trans. R. Soc. Trop. Med. Hyg. 81:1987;343-344.
37. Munst G.J., Karlaganis G., Bircher J. Plasma concentration of mebendazole during treatment of echinococcosis. Eur. J. Clin. Pharmacol. 17:1980;375-378.
38. Muttalib M.A., Khan M.U., Haq J.A. Single dose regime of mebendazole in the treatment of polyparasitism in children. J. Trop. Med. Hyg. 84:1981;159-160.
39. Olds G.R., King C., Hewlett J., Olveda R., Wu G., Ouma J., Peters P., McGarvey S., Odhiambo O., Koech D., Liu C.Y., Aligui G., Gachihi G., Kombe Y., Parraga I., Ramirez B., Whalen C., Horton R.J., Reeve P. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J. Infect. Dis. 179:(4):1999;996-1003.
40. Pitts N.E., Migliardi J.R. Antiminth (pyrantel pamoate): the clinical evaluation of a new broad-spectrum anthelminthic. Pediatrics. 13:1974;87-94.
41. Reuter S., Jensen B., Buttenschoen K., Kratzer W., Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother. 46:(3):2000;451-456.
42. Rossignol J.F., Maissonneuve H. Albendazole: placebo controlled study in 870 patients with intestinal helminths. Trans. R. Soc. Trop. Med. Hyg. 77:(5):1983;707-711.
43. Sasongko, A., Lubis, F., Mahaswiati, M., Ratnawulan, D., 2003. Practical experience from the primary school-based soil-transmitted helminth control program in Jakarta 1987-1999. In: Crompton, D.W.T., Montresor, A., Nesheim, M.C., Savioli, L. (Eds.). Controlling Disease due to Soil-Transmitted Helminths 1987, World Health Organization, Geneva, in press.
44. Savioli L., Bundy D.A.P., Tomkins A. Intestinal parasitic infections: a soluble public health problem. Trans. R. Soc. Trop. Med. Hyg. 86:1992;353-354.
45. Stoltzfus R.J., Kvalsvig J.D., Chwaya H.M., Montresor A., Albonico M., Tielsch J.M., Savioli L., Pollitt E. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. Br. Med. J. 323:(7326):2001;1389.
46. Urbani C., Palmer K. Drug-based helminth control in Western Pacific countries: a general perspective. Trop. Med. Int. Health. 6:(11):2001;935-944.
47. van den Bossche H., Rochette F., Horig C. Mebendazole and related anthelminthics. Adv. Pharmacol. Chemother. 19:1982;67-128.
48. Webster L.T. Drugs used in the chemotherapy of helminthiasis. Goodman Gilman A., Rall T.W., Nies A.S., Taylor P. The Pharmacological Basis of Therapeutics. eighth ed:1991;959-977 Pergamon Press.
49. Wen H., Zhang H.W., Muhmut M., Zou P.F., New R.R., Craig P.S. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Ann. Trop. Med. Parasitol. 88:(1):1994;49-52.
50. Wilmshurst J.M., Robb S.A. Can mebendazole cause lateralized occipital seizures. Eur. J. Paediatr. Neurol. 2:(6):1998;323-324.
51. World Health Organization (WHO), 1995. WHO Model Prescribing Information. Drugs used in parasitic diseases, second ed., Geneva.
52. World Health Organization (WHO), 1996a. Report of the WHO informal consultation on the use of chemotherapy for the control of morbidity due to soil-transmitted nematodes in humans. Geneva 29 April to 1 May 1996. Division of Control of Tropical Diseases. WHO/CTD/SIP.96.2. Geneva.
53. World Health Organization (WHO), 1996b. Report of the WHO Informal Consultation on hookworm infection and anaemia in girls and women. Division of Control of Tropical Diseases, WHO/CTD/SIP.96.1. Geneva.
54. World Health Organization (WHO), 1997. The use of essential drugs. WHO Technical Report Series no. 867. Geneva.
55. World Health Organization (WHO), 2000. Control of schistosomiasis and soil-transmitted helminth infections. Report by secretariat. 27 October 2000. Division of Communicable Diseases, EB107/31.
56. Zheng, R.Y., Jiang, Z.C., Zhang, X., 1992. Relationship between levamisole and encephalitis syndrome. Chung Hua Nei Ko Tsa Chih 31(9), 530-2, 585.